Geert Leroux-Roels a, Isabel Leroux-Roels a. The Lancet Infectious Diseases, Early Online Publication, 17 December 2010
In The Lancet Infectious Diseases today, Karl Nicholson and colleagues 1 present the results of the first head-to-head comparison in adults of the immunogenicity and safety of the whole-virion influenza A H1N1 2009 vaccine (Baxter, Vienna, Austria; 7·5 μg haemagglutinin) and the AS03 A -adjuvanted split-virion influenza A H1N1 2009 (GlaxoSmithKline, Dresden, Germany; 3·75 μg haemagglutinin) vaccines. The measurement of antibody titres with one standardised method in a single laboratory allows for a di ...
Weblink here
